WFSBP Programme 2015

60 / 112

58
WFSBP 2015
Scientific Programme | Wednesday, 17 June 2015
PL-03 Plenary lecture
10:00–10:45 Trianti Hall
Chair: Masatoshi Takeda, Japan
PL-03-001
Neuropsychiatric syndromes of later life: Implications for
the study and treatment of major psychiatric diseases
Constantine Lyketsos, USA
T10: Depression: Basic / Clinical
S-31 Symposium
08:30–10:00 Trianti Hall
Novel biomarkers in mood disorders: Opportunities for
translation into clinical practice
Chair: Bernhard Baune, Australia
Co-Chair: Kenji Hashimoto, Japan
S-31-001
A translational perspective on the neurotrophin hypothesis
of depression
Marc L. Molendijk, The Netherlands
S-31-002
BDNF and its precursor proBDNF as biomarkers for mood
disorders
Kenji Hashimoto, Japan
S-31-003
Apoptosis as new biomarker for mood disorders
Yakup Albayrak, Turkey
S-31-004
Genetic and serum immune biomarkers in depression
Bernhard Baune, Australia
T40: Schizophrenia: Basic / Clinical
S-32 Symposium
08:30–10:00 Mitropoulos Hall
Biological markers of cognitive deficits and negative
symptoms in schizophrenia
Chair: Nash N. Boutros, USA
Co-Chair: Adam Wichniak, Poland
S-32-001
Need for assessment batteries to examine cognition in
deficit syndrome patients
Nash N. Boutros, USA
K. Gjini, F. Wang, S. Bowyer
S-32-002
Negative symptoms in schizophrenia: Main issues in the
search for biomarkers
Silvana Galderisi, Italy
A. Vignapiano, P. Bucci, A. Mucci
S-32-003
Quantitative analysis of neurophysiological signals as bio-
logical marker of cognitive deficits and negative symptoms
in schizophrenia
Adam Wichniak, Poland
S-32-004
WFSBP-Consensus criteria for neurophysiological biomark-
ers and endophenotypes of schizophrenia
Florence Thibaut, France
T46: Suicide: Basic/ Clinical
S-33 Symposium
08:30–10:00 Skalkotas Hall
Translational psychiatry in mood disorders and suicide
Chair: Julio Licinio, Australia
Co-Chair: Philippe Courtet, France
S-33-001
Imaging and cognitive markers of suicidal behavior
Fabrice Jollant, Canada
S-33-002
Omics predictors of suicidal behaviour
Enrique Baca Garcia, Spain
S-33-003
The role of neuroinflammation and immunity on suicidality
Philippe Courtet, France
S-33-004
Serotonin and endocannabinoid system in mood disorders:
Animal and clinical studies
Gabriella Gobbi, Canada
T32: Pharmacology
S-34 Symposium
08:30–10:00 MC 3 Room
Cross species studies of psychedelic drugs–relevance to
psychiatric disorders
Chair: Franz Vollenweider, Switzerland
Co-Chair: Mark A. Geyer, USA
S-34-001
Behavioral and pharmacological studies of psychedelics
in animals
Mark A. Geyer, USA